retatrutide clinical trial saudi arabia New data released on weight loss drug Retatrutide Results: 28.3% Weight Loss

Similarly the weight loss seen with Exenatide and some other early GLP-1 drugs was thought too limited to win approval for the treatment of obesity (Gilbert, Rosenthal, March 2024)

Metabolic Rate Retatrutides impact on metabolic rate is key to its influence on body composition

Why do so many patients know what they should do but still struggle to do it

Industry disclosure: lead author Alec Semersky is identified in the publication as a product developer at Afor, LLC, the manufacturer of the GLPSGLT topical serum tested

During most weight loss programs including GLP-1 medications the body can lose both: fat mass lean muscle mass Some early studies suggest 1040% of weight lost may include lean tissue , depending on diet and activity levels